Accrued Liabilities and Other Liabilities

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Accrued Liabilities and Other Liabilities

Accrued liabilities and other liabilities consisted of the following (in thousands):

	September 30,		December 31,
	2023		2022
Accrued liabilities:
Accrued clinical expense	$	35,184	$	37,604
Accrued manufacturing expense	5,310		6,605
Accrued development expense	5,006		20,107
Accrued compensation and benefits	34,495		40,208
Accrued commercial expense	2,920		3,941
Accrued royalty expense	1,187		—
Accrued adjustments to product revenue	2,772		152
Lease liability (current)	8,020		7,844
Other accrued expenses	4,524		4,126
Total accrued liabilities	$	99,418	$	120,587
Other liabilities	$	3,661	$	3,022

Other liabilities as of September 30, 2023 and December 31, 2022 consisted primarily of clinical trial-related liabilities.